However, it is associated with considerable risk of hypoglycemia and weight gain [5]
In July 2025, AstraZeneca committed to investing USD 50 billion in the United States through 2030 a manufacturing and R&D commitment that reflects confidence in US market growth
The five-year cap and the 14-year cap interact to produce a range of outcomes depending on development timeline, and the arithmetic of this interaction is a discrete analytical skill that IP teams need to perform correctly before a drug launches
These findings suggest that GLP-1 agonists be used in patients who would benefit from weight loss in real-world settings, White said
Then, we will begin to gather evidence, such as medical records and witness testimony to build a robust case on your behalf
This mechanism reduces appetite and increases satiety, supporting weight loss and ongoing weight management